All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines.
In order to investigate the direct effects of retinoids on normal adult hematopoietic progenitors, purified CD34+ cells were seeded in serum-free cultures in the presence of pharmacological (10(-6)) M or physiological (10(-12)) M concentrations of all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9-cis RA) plus combinations of specific cytokines. 10(-6) M ATRA and 9-cis RA significantly decreased the number of granulomacrophagic, erythroid and megakaryocytic (CFU-meg) progenitors. On the other hand, 10(-12) M ATRA significantly promoted the growth of CFU-meg, in the presence either of thrombopoietin or of IL-3+ GM-CSF, and induced a reproducible stimulation of the immature CD34+DR- subset. In conclusion, our findings suggest that retinoic acids probably play a direct role in normal adult hematopoietic development at both physiological and pharmacological concentrations. The stimulatory effect on megakaryocytopoiesis should be considered in the perspective of a potential use of low-dose ATRA, combined with thrombopoietin or other cytokines, in pathological conditions where the megakaryocytic compartment is impaired and the stimulation of megakaryocytopoiesis is requested.
Visani
G
G
Insititute of Hematology and Medical Oncology Serágnoli, University of Bologna, Italy. Gvisani@med.unibo.it
Ottaviani
E
E
Zauli
G
G
Tosi
P
P
Pellacani
A
A
Isidori
A
A
Pierpaoli
S
S
Tura
S
S
D000328:Adult; D018952:Antigens, CD34 / Q000032:analysis; D002469:Cell Separation; D003114:Colony-Forming Units Assay; D016207:Cytokines / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D015672:Erythroid Precursor Cells / Q000166:cytology / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects*; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D008533:Megakaryocytes / Q000166:cytology / Q000187:drug effects*; D013926:Thrombopoietin / Q000494:pharmacology*; D014212:Tretinoin / Q000494:pharmacology*
D018952:Antigens, CD34; D016207:Cytokines; D007377:Interleukin-3; D014212:Tretinoin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D013926:Thrombopoietin